MedTrace Logo

The Effect of Clinical Monitoring Software on Symptoms in Patients With Chronic Low Back Pain

NCT05816824 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2023-08-08

No results posted yet for this study

Summary

The aim of this randomised controlled trial is to compare the effectiveness of two different telerehabilitation assessment methods in patients with chronic low back pain. The control group will receive a video exercise-based rehabilitation protocol with telerehabilitation. The intervention group will be followed up with the same protocol plus symptom monitoring software called PhysioAnalyst which provides visual feedback. The evaluation of outcome measures will be performed on the control group through the PhysioAnalist programme without visual feedback and on the intervention group through the PhysioAnalist programme with visual feedback.

Conditions

Interventions

OTHER

Symptom monitoring software via visual feedback

With PhysioAnalyst software, individuals are evaluated using clinical tools (questionnaire, scale). These evaluations provide visual feedback to individuals in the form of tables and graphs. In this way, patients can observe the changes in their clinical status.

Sponsors & Collaborators

  • Muğla Sıtkı Koçman University

    lead OTHER

Principal Investigators

  • Fatih Özden, PhD · Muğla Sıtkı Koçman University

  • Bekir Güçlü, MSc · Istanbul Halic University

  • İsmet Tümtürk, MSc · Süleyman Demirel University

  • Ahmet İmerci, MD · Muğla Sıtkı Koçman University

  • Baki Umut Tuğay, PhD · Muğla Sıtkı Koçman University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-30
Primary Completion
2023-07-05
Completion
2023-08-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05816824 on ClinicalTrials.gov